Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2001 1
2003 1
2004 1
2005 2
2006 2
2007 2
2008 1
2012 1
2014 2
2016 3
2017 3
2018 5
2019 1
2020 3
2021 6
2022 9
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
Christodoulou I, Ho WJ, Marple A, Ravich JW, Tam A, Rahnama R, Fearnow A, Rietberg C, Yanik S, Solomou EE, Varadhan R, Koldobskiy MA, Bonifant CL. Christodoulou I, et al. Among authors: bonifant cl. J Immunother Cancer. 2021 Dec;9(12):e003894. doi: 10.1136/jitc-2021-003894. J Immunother Cancer. 2021. PMID: 34896980 Free PMC article.
Engineering builds multipotency for iPSC-NKs.
Rahnama R, Bonifant CL. Rahnama R, et al. Among authors: bonifant cl. Blood. 2022 Dec 8;140(23):2414-2416. doi: 10.1182/blood.2022017794. Blood. 2022. PMID: 36480219 Free article. No abstract available.
Improving CAR T-cells: The next generation.
Marple AH, Bonifant CL, Shah NN. Marple AH, et al. Among authors: bonifant cl. Semin Hematol. 2020 Jul;57(3):115-121. doi: 10.1053/j.seminhematol.2020.07.002. Epub 2020 Jul 23. Semin Hematol. 2020. PMID: 33256900 Review.
Targeting glycans for CAR therapy: The advent of sweet CARs.
Raglow Z, McKenna MK, Bonifant CL, Wang W, Pasca di Magliano M, Stadlmann J, Penninger JM, Cummings RD, Brenner MK, Markovitz DM. Raglow Z, et al. Among authors: bonifant cl. Mol Ther. 2022 Sep 7;30(9):2881-2890. doi: 10.1016/j.ymthe.2022.07.006. Epub 2022 Jul 12. Mol Ther. 2022. PMID: 35821636 Free PMC article. Review.
Toxicity and management in CAR T-cell therapy.
Bonifant CL, Jackson HJ, Brentjens RJ, Curran KJ. Bonifant CL, et al. Mol Ther Oncolytics. 2016 Apr 20;3:16011. doi: 10.1038/mto.2016.11. eCollection 2016. Mol Ther Oncolytics. 2016. PMID: 27626062 Free PMC article. Review.
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine.
Karantanos T, Teodorescu P, Arvanitis M, Perkins B, Jain T, DeZern AE, Dalton WB, Christodoulou I, Paun BC, Varadhan R, Esteb C, Rajkhowa T, Bonifant C, Gondek LP, Levis MJ, Yegnasubramanian S, Ghiaur G, Jones RJ. Karantanos T, et al. Among authors: bonifant c. Haematologica. 2023 Jul 1;108(7):1886-1899. doi: 10.3324/haematol.2022.281444. Haematologica. 2023. PMID: 36519323 Free PMC article.
47 results